Comparison of measles virus-specific antibody titres as measured by enzyme-linked immunosorbent assay and virus neutralisation assay

Vaccine

Volumn 21, Issue 27-30, 2003, Pages 4210-4214

  Van Den Hof, Susan ^a   Van Gageldonk Lafeber, Arianne B ^a   Van Binnendijk, Robert S ^a   Van Gageldonk, Pieter G M ^a   Berbers, Guy A M ^a  

^a NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

ELISA; Measles antibodies; Neutralisation

Indexed keywords

MEASLES ANTIBODY; MEASLES VACCINE;

ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BLOOD ANALYSIS; CHILD; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOSURVEILLANCE; INTERMETHOD COMPARISON; MEASLES; MEASLES VIRUS; OUTCOMES RESEARCH; POPULATION RESEARCH; PRIORITY JOURNAL; SEROPREVALENCE; STATISTICAL SIGNIFICANCE; VIRUS NEUTRALIZATION;

EID: 0346186990     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00490-0     Document Type: Article

References (18)

1. van den Hof S., Berbers G.A.M., de Melker H.E., Conyn-van Spaendonck M.A.E. Seroepidemiology of measles antibodies in The Netherlands. Vaccine. 18(2000):1999;931-940.
2. de Melker H.E., Conyn-van Spaendonck M.A.E. Immunosurveillance and the evaluation of national immunisation programmes a population-based approach. Epidemiol. Infect. 21(3):1998;637-643.
3. Harmsen T., Jongerius M.C., Zwan C.W., van der Plantinga A.D., Kraaijeveld C.A., Berbers G.A.M. Comparison of neutralisation enzyme immunoassay and enzyme-linked immunosorbent assay for evaluation of the immune status of mumps vaccinated children. J. Clin. Microbiol. 30(8):1992;2139-2144.
4. Christenson B., Böttiger M. Methods for screening the naturally acquired and vaccine-induced immunity to the measles virus. Biologicals. 18(3):1990;207-211.
5. Chen R.T., Markowitz L.E., Albrecht P.et al. Measles antibody: reevaluation of protective titers. J. Infect. Dis. 162(5):1990;1036-1042.
6. van Binnendijk RS, van den Hof S, van den Kerkhof JHTC, et al. Evaluation of serological and virological tests in the diagnosis of apparent and inapparent measles virus infections during an outbreak of measles in The Netherlands. J Infect Dis, in press.
7. Forsey T., Heath A.B., Minor F.D. The first international standard for anti-measles serum. Biologicals. 19(3):1991;237-241.
8. Forsey T. International reference preparation for anti-measles serum. Biologicals. 20(1):1991;87.
9. Markowitz LE, Katz SL. Measles vaccine. In: Plotkin SA, Mortimer Jr EA, editors. Vaccines. 2nd ed. Philadelphia: Saunders; 1994. p. 229-76.
10. Neumann P.W., Weber J.M., Jessamine A.G., O'Shaughnessy M.V. Comparison of measles antihemolysin test, enzyme-linked immunosorbent assay and hemagglutination inhibition test with neutralization test for determination of immune status. J. Clin. Microbiol. 22(2):1985;296-298.
11. Christenson B., Böttiger M. Measles antibody: comparison of long-term vaccination titres, early vaccination titres and naturally acquired immunity to and booster effects on the measles virus. Vaccine. 12(2):1994;129-133.
12. Dagan R., Slater P.E., Dubdevani P., Golubev N., Mendelson E. Decay of maternally derived measles antibody in a highly vaccinated population in southern Israel. Pediatr. Infect. Dis. J. 14(11):1995;965-969.
13. Bass J.W., Halstead S.B., Fischer G.W.et al. Booster vaccination with further live attenuated measles vaccine. J. Am. Med. Assoc. 235(1):1976;31-34.
14. Markowitz L.E., Albrecht P., Orenstein W.A., Lett S.M., Pugliese T.J. Persistence of measles antibody after revaccination. J. Infect. Dis. 166(1):1992;205-208.
15. Ward B.J., Boulianne N., Ratnam S., Guiot M.-C., Couillard M., De Serres G. Cellular immunity in measles vaccine failure: demonstration of measles antigen-specific lymphoproliferative responses despite limited serum antibody production after revaccination. J. Infect. Dis. 172(6):1995;1591-1595.
16. Huiss S., Damien B., Schneider F., Müller C.P. Characteristics of asymptomatic secondary immune responses to measles virus in late convalescent donors. Clin. Exp. Immunol. 109(3):1997;416-420.
17. Wallinga J., van den Hof S. Epidemiologie van mazelen in Nederland: een verkennende analyse van aangiften. Ned. Tijdschr. Geneeskd. 144(4):2000;171-174.
18. World Health Organization. The immunological basis for immunization series. Module 1: general immunology. WHO/EPI/GEN/93.11. Geneva, Switzerland, 1993.